Pharmacovigilance Market Size, Share & Trends Analysis Report By Service Provider (In-house, Contract Outsourcing), By Product Life Cycle, By Therapeutic Area, By Process Flow, By End-Use, By Type, And Segment Forecasts, 2023 - 2030
- Report ID: 978-1-68038-327-0
- Number of Pages: 298
- Format: Electronic (PDF)
- Historical Range: 2018 - 2023
- Industry: Healthcare
Market Segmentation
- Pharmacovigilance Product Life Cycle Outlook (Revenue, USD Million, 2018 - 2030)
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Pharmacovigilance Service Provider Outlook (Revenue, USD Million, 2018 - 2030)
- In-house
- Contract Outsourcing
- Pharmacovigilance Type Outlook (Revenue, USD Million,2018 - 2030)
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Pharmacovigilance Process Flow Outlook (Revenue, USD Million,2018 - 2030)
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Pharmacovigilance Therapeutic Area Outlook (Revenue, USD Million,2018 - 2030)
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Pharmacovigilance End Use Outlook (Revenue, USD Million,2018 - 2030)
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Pharmacovigilance Regional Outlook (USD Million,2018 - 2030)
- North America
- North America Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- North America Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- North America Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- North America Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- North America Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- North America Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- U.S.
- U.S. Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- U.S. Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- U.S. Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- U.S. Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- U.S. Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- U.S. Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- U.S. Pharmacovigilance Market, by Product Life Cycle
- Canada
- Canada Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Canada Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Canada Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Canada Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Canada Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Canada Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Canada Pharmacovigilance Market, by Product Life Cycle
- North America Pharmacovigilance Market, by Product Life Cycle
- Europe
- Europe Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Europe Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Europe Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Europe Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Europe Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Europe Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- UK
- UK Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- UK Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- UK Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- UK Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- UK Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- UK. Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- UK Pharmacovigilance Market, by Product Life Cycle
- Germany
- Germany Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Germany Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Germany Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Germany Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Germany Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Germany Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Germany Pharmacovigilance Market, by Product Life Cycle
- France
- France Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- France Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- France Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- France Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- France Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- France Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- France Pharmacovigilance Market, by Product Life Cycle
- Italy
- Italy Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Italy Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Italy Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Italy Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Italy Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Italy Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Italy Pharmacovigilance Market, by Product Life Cycle
- Spain
- Spain Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Spain Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Spain Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Spain Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- U.S. Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- U.S. Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Spain Pharmacovigilance Market, by Product Life Cycle
- Denmark
- Denmark Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Denmark Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Denmark Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Denmark Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Denmark Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Denmark Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Denmark Pharmacovigilance Market, by Product Life Cycle
- Sweden
- Sweden Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Sweden Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Sweden Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Sweden Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Sweden Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Sweden Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Sweden Pharmacovigilance Market, by Product Life Cycle
- Norway
- Norway Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Norway Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Norway Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Norway Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Norway Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Norway Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Norway Pharmacovigilance Market, by Product Life Cycle
- Russia
- Russia Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Russia Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Russia Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Russia Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Russia Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Russia Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Russia Pharmacovigilance Market, by Product Life Cycle
- Rest of Europe
- Rest of Europe Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Rest of Europe Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Rest of Europe Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Rest of Europe Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Rest of Europe Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Rest of Europe Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Rest of Europe Pharmacovigilance Market, by Product Life Cycle
- Europe Pharmacovigilance Market, by Product Life Cycle
- Asia Pacific
- Asia Pacific Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Asia Pacific Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Asia Pacific Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Asia Pacific Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Asia Pacific Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Asia Pacific Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Japan
- Japan Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Japan Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Japan Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Japan Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Japan Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Japan Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Japan Pharmacovigilance Market, by Product Life Cycle
- China
- China Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- China Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- China Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- China Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- China Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- China Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- China Pharmacovigilance Market, by Product Life Cycle
- India
- India Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- India Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- India Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- India Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- India Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- India Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- India Pharmacovigilance Market, by Product Life Cycle
- Australia
- Australia Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Australia Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Australia Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Australia Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Australia Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Australia Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Australia Pharmacovigilance Market, by Product Life Cycle
- Thailand
- Thailand Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Thailand Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Thailand Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Thailand Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Thailand Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Thailand Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Thailand Pharmacovigilance Market, by Product Life Cycle
- South Korea
- South Korea Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- South Korea Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- South Korea Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- South Korea Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- South Korea Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- South Korea Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- South Korea Pharmacovigilance Market, by Product Life Cycle
- Rest of Asia Pacific
- Rest of Asia Pacific Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Rest of Asia Pacific Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Rest of Asia Pacific Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Rest of Asia Pacific Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Rest of Asia Pacific Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Rest of Asia Pacific Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Rest of Asia Pacific Pharmacovigilance Market, by Product Life Cycle
- Asia Pacific Pharmacovigilance Market, by Product Life Cycle
- Latin America
- Latin America Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Latin America Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Latin America Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Latin America Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Latin America Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Latin America Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Brazil
- Brazil Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Brazil Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Brazil Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Brazil. Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Brazil Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Brazil Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Brazil Pharmacovigilance Market, by Product Life Cycle
- Mexico
- Mexico Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Mexico Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Mexico Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Mexico Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Mexico Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Mexico Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Mexico Pharmacovigilance Market, by Product Life Cycle
- Argentina
- Argentina Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Argentina Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Argentina Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Argentina Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Argentina Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Argentina Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Argentina Pharmacovigilance Market, by Product Life Cycle
- Rest of Latin America
- Rest of Latin America Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Rest of Latin America Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Rest of Latin America Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Rest of Latin America Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Rest of Latin America Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Rest of Latin America Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Rest of Latin America Pharmacovigilance Market, by Product Life Cycle
- Latin America Pharmacovigilance Market, by Product Life Cycle
- The Middle East and Africa
- The Middle East and Africa Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- The Middle East and Africa Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- The Middle East and Africa Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- The Middle East and Africa. Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- The Middle East and Africa Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- The Middle East and Africa Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- South Africa
- South Africa. Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- South Africa Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- South Africa Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- South Africa Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- South Africa Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- South Africa Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- South Africa. Pharmacovigilance Market, by Product Life Cycle
- Saudi Arabia
- Saudi Arabia Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Saudi Arabia Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Saudi Arabia Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Saudi Arabia Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Saudi Arabia Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Saudi Arabia Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Saudi Arabia Pharmacovigilance Market, by Product Life Cycle
- UAE
- UAE Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- UAE Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- UAE Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- UAE Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- U.S. Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- U.S. Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- UAE Pharmacovigilance Market, by Product Life Cycle
- Kuwait
- Kuwait Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Kuwait Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Kuwait Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Kuwait Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Kuwait Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Kuwait Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Kuwait Pharmacovigilance Market, by Product Life Cycle
- Rest of MEA
- Rest of MEA Pharmacovigilance Market, by Product Life Cycle
- Pre-clinical
- Phase I
- Phase II
- Phase III
- Phase IV
- Rest of MEA Pharmacovigilance Market, by Service Provider
- In-house
- Contract Outsourcing
- Rest of MEA Pharmacovigilance Market, by Type
- Spontaneous Reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
- Rest of MEA Pharmacovigilance Market, by Process flow
- Case Data Management
- Case Logging
- Case Data Analysis
- Medical Reviewing & Reporting
- Signal Detection
- Adverse Event Logging
- Adverse Event Analysis
- Adverse Event Review & Reporting
- Risk Management System
- Risk Evaluation System
- Risk Mitigation System
- Case Data Management
- Rest of MEA Pharmacovigilance Market, by Therapeutic Area
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
- Rest of MEA Pharmacovigilance Market, by End Use
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
- Rest of MEA Pharmacovigilance Market, by Product Life Cycle
- The Middle East and Africa Pharmacovigilance Market, by Product Life Cycle
- North America
Pharmacovigilance Market Dynamics
Drivers: Growing Drug Consumption And Drug Development Rates
Drug consumption has increased substantially owing to the rapidly growing prevalence of diseases. The rise in the incidence of chronic diseases, such as cancers, diabetes, and cardiovascular and respiratory disorders, has led to an increase in drug consumption worldwide. According to a WHO report on pharmaceutical consumption, medicines to treat chronic diseases accounted for a more significant proportion of the total volume of drug consumption in nonhospital setups. Furthermore, there has been a substantial rise in the number of drugs made available to healthcare consumers. The rising demand for drugs has significantly increased the need for new drug development via extensive clinical trials. Manufacturers are now focusing on remodeling their drug development processes to cater to patient needs across the globe. The presence of a competitive milieu has led to improved manufacturing operations, pharmacovigilance, clinical data management, streamlined R&D, and medical writing. Manufacturers are rapidly considering outsourcing as a viable cost-curbing tool.
Increasing Incidence Of Adr And Drug Toxicity
ADR imposes a substantial burden on healthcare systems and is one of the prominent causes of morbidity in developed countries. According to the National Center for Biotechnology Information (NCBI), approximately 5% of total hospitalizations in Europe in a year are due to ADR. In February 2022, an article was published in the Journal of Current Medicine Research and Practice titled "Characterization of Seriousness and Outcome of Adverse Drug Reactions in Patients Receiving Cancer Chemotherapy Drugs – A Prospective Observational Study." The article revealed that in the United States, severe Adverse Drug Reactions (ADRs) result in over 100,000 deaths annually, which has been a significant health concern for the past decade. ADRs, like fatal arrhythmia and liver failure, can lead to withdrawal of a drug from the market, as the risks associated with the drug use outweigh its benefits.
Restraints: Shortage Of Skilled Labor
Timely evaluation of drug safety is of paramount importance. Lack of availability of skilled labor, especially in the emerging Asia Pacific region, is expected to restrain market growth over the forecast period. The increase in pharmaceutical and biotechnology companies worldwide has led to a rise in the number of products in the market, which demands efficient PV services. Regulatory policies vary across countries, making it difficult for service providers to meet staffing requirements. Moreover, pharmacovigilance is a continuously evolving process; therefore, researchers need to constantly educate themselves in line with the frequent changes in rules and regulations.
What Does This Report Include?
This section will provide insights into the contents included in this pharmacovigilance market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.
Pharmacovigilance market qualitative analysis
-
Industry overview
-
Industry trends
-
Market drivers and restraints
-
Market size
-
Growth prospects
-
Porter’s analysis
-
PESTEL analysis
-
Key market opportunities prioritized
-
Competitive landscape
-
Company overview
-
Financial performance
-
Product benchmarking
-
Latest strategic developments
-
Pharmacovigilance market quantitative analysis
-
Market size, estimates, and forecast from 2018 to 2030
-
Market estimates and forecast for product segments up to 2030
-
Regional market size and forecast for product segments up to 2030
-
Market estimates and forecast for application segments up to 2030
-
Regional market size and forecast for application segments up to 2030
-
Company financial performance
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
ESOMAR certified & member
ISO Certified
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.
